GPX4 and cancer: The current ferroptosis-inducing strategies used to eliminate therapy-resistant cancer cells usually target GPX4 by downregulating its expression [58] or by inhibiting its activity via the reduction of its cofactor, GSH [59], thus disturbing the balance between prooxidant and antioxidant systems.